신경 내시경 기기 시장 규모, 점유율, 성장률 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of Neuroendoscopy Devices Market

The global Neuroendoscopy Devices Market was valued at USD 442.98 million in 2025 and is projected to grow from USD 495.87 million in 2026 to USD 1,222.51 million by 2034, registering a CAGR of 11.94% during 2026-2034. North America dominated the global market with a 47.49% share in 2025. Neuroendoscopy is a minimally invasive surgical approach that enables neurosurgeons to access difficult areas of the brain through small openings in the skull or through the nose and mouth.

Market Size and Market Value

The Neuroendoscopy Devices Market Size reached USD 442.98 million in 2025. The market is expected to increase to USD 495.87 million in 2026 and reach USD 1,222.51 million by 2034. Increasing adoption of minimally invasive neurosurgical procedures, rising incidence of brain tumors, technological advancements in neuroendoscopes, and growth in the geriatric population are supporting market expansion.

Improved imaging, fiber optics, visualization systems, and surgical instruments are making neuroendoscopic procedures more precise and less invasive. These developments are encouraging healthcare providers to adopt advanced neuroendoscopy devices.

Market Trends

A key Neuroendoscopy Devices Market Trend is the increasing shift toward minimally invasive neurosurgery. Rigid neuroendoscopes continue to have strong adoption because of their high-resolution visualization and established use in surgical procedures. At the same time, flexible neuroendoscopes are gaining attention because of technological improvements and their ability to access complex anatomical areas.

Growing awareness of minimally invasive procedures and increasing healthcare infrastructure in emerging economies are also supporting market development.

Market Drivers

Rising Incidence of Brain Tumors: The growing prevalence of brain tumors is increasing the demand for diagnostic and therapeutic neuroendoscopic procedures. Trauma and spinal cord injuries also contribute to demand for advanced neurological surgical technologies.

Technological Advancements: Improvements in imaging, fiber optics, neuroimaging, and surgical instruments are enhancing visualization and procedural accuracy. These innovations are expanding the applications of neuroendoscopy.

Growing Geriatric Population: Increasing numbers of people aged 65 years and above are contributing to demand because elderly populations face a higher burden of chronic neurological conditions.

Market Restraints and Challenges

High costs associated with neuroendoscopy devices and procedures remain a major market challenge. The technology requires specialized equipment, trained neurosurgeons, and advanced hospital infrastructure. Limited awareness of minimally invasive neurosurgical procedures in some developing regions and restricted access to advanced technologies can also slow adoption.

Market Segmentation

By Product Type, the market is divided into rigid and flexible neuroendoscopes. Rigid neuroendoscopes are expected to maintain a significant position because of their established use and high-resolution optical systems. The source also indicates that the metal plates & screws segment accounted for 83.10% in 2025.

By Application, the market includes transnasal, intraventricular, and transcranial neuroendoscopy. Transnasal neuroendoscopy is projected to maintain a leading position, supported by its application in pituitary tumor and cyst removal and access to complex cranial regions.

By End User, the market is segmented into hospitals and specialty clinics. Hospitals accounted for the maximum share, supported by advanced facilities, increasing neurosurgical procedures, and favorable healthcare infrastructure.

Regional Analysis

North America dominated the market with a 47.49% share in 2025. The region benefits from advanced healthcare infrastructure, increasing demand for minimally invasive procedures, major industry participants, and growing treatment requirements for neurological conditions.

Asia Pacific is anticipated to register exponential growth due to increasing brain tumor prevalence, healthcare expenditure, improving medical infrastructure, and a growing elderly population. Japan's market reached USD 12.1 million in 2025, while China is projected to record strong growth.

Europe is expected to grow at a 7.10% CAGR during the forecast period, supported by increasing prevalence of pituitary tumors and the presence of experienced neurosurgeons. The Middle East & Africa and Latin America represent emerging opportunities as healthcare infrastructure develops.

Key Industry Players

Major companies include B. Braun Aesculap, KARL STORZ SE & Co. KG, Ackermann Instrumente GmbH, Clarus Medical LLC, Schindlerendoskopie Technologie GmbH, Tonglu WANHE Medical Instrument, HAWK, Machida Endoscope, Adeor Medical AG, and Nevro Corporation. The market remains fragmented, with established manufacturers and emerging companies competing through technological innovation and product development.

Recent Industry Development

In November 2024, Adeor announced the opening of a new branch office in the United States to strengthen distribution and support for its neurosurgical products.

Investment Analysis and Opportunities

The market offers investment opportunities in advanced rigid and flexible neuroendoscopes, high-resolution visualization systems, minimally invasive surgical instruments, and technologies designed for complex neurological procedures. Asia Pacific provides significant expansion potential because of improving healthcare infrastructure and rising healthcare expenditure. Continued product innovation and increasing demand for less invasive surgeries are expected to create additional opportunities for manufacturers.

Conclusion

The Neuroendoscopy Devices Market is projected to expand from USD 442.98 million in 2025 to USD 495.87 million in 2026 and reach USD 1,222.51 million by 2034. Rising brain tumor incidence, technological advancements, growing geriatric populations, and increasing preference for minimally invasive neurosurgery are driving market growth. North America remains the leading region, while Asia Pacific represents a high-growth opportunity. Continued innovation in neuroendoscopic visualization, flexible devices, and surgical technologies is expected to strengthen the market outlook through 2034.

Unit Value (USD million)

Segmentation By Product Type

• Rigid Neuroendoscopes
• Flexible Neuroendoscopes

By Application

• Transnasal Neuroendoscopy
• Intraventricular Neuroendoscopy
• Transcranial Neuroendoscopy

By End User

• Hospitals
• Specialty Clinics
• Others

By Geography

• North America (the U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East and Africa ( South Africa, GCC, and the Rest of the Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Industry Background of Neuroendoscopy Devices
• 4.2. New Product Launch
• 4.3. Key Merger and Acquisition Strategies by Top Players
• 4.4. Overview on Technological Advancements Pertaining to the Neuroendoscopes
• 4.5. Statistics on Prevalence of Brain Tumors across Key Countries
• 4.6. Data Pertaining to Healthcare Expenditure for Key Countries

5. Global Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Rigid Neuroendoscopes
  • 5.2.2. Flexible Neuroendoscopes
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Transnasal Neuroendoscopy
  • 5.3.2. Intraventricular Neuroendoscopy
  • 5.3.3. Transcranial Neuroendoscopy
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product Type
  • 6.2.1. Rigid Neuroendoscopes
  • 6.2.2. Flexible Neuroendoscopes
• 6.3. Market Analysis - By Application
  • 6.3.1. Transnasal Neuroendoscopy
  • 6.3.2. Intraventricular Neuroendoscopy
  • 6.3.3. Transcranial Neuroendoscopy
• 6.4. Market Analysis - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis - By Country/ Sub-region
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product Type
  • 7.2.1. Rigid Neuroendoscopes
  • 7.2.2. Flexible Neuroendoscopes
• 7.3. Market Analysis - By Application
  • 7.3.1. Transnasal Neuroendoscopy
  • 7.3.2. Intraventricular Neuroendoscopy
  • 7.3.3. Transcranial Neuroendoscopy
• 7.4. Market Analysis - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis - By Country/ Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product Type
  • 8.2.1. Rigid Neuroendoscopes
  • 8.2.2. Flexible Neuroendoscopes
• 8.3. Market Analysis - By Application
  • 8.3.1. Transnasal Neuroendoscopy
  • 8.3.2. Intraventricular Neuroendoscopy
  • 8.3.3. Transcranial Neuroendoscopy
• 8.4. Market Analysis - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis - By Country/ Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product Type
  • 9.2.1. Rigid Neuroendoscopes
  • 9.2.2. Flexible Neuroendoscopes
• 9.3. Market Analysis - By Application
  • 9.3.1. Transnasal Neuroendoscopy
  • 9.3.2. Intraventricular Neuroendoscopy
  • 9.3.3. Transcranial Neuroendoscopy
• 9.4. Market Analysis - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. Market Analysis - By Country/ Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Neuroendoscopy Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product Type
  • 10.2.1. Rigid Neuroendoscopes
  • 10.2.2. Flexible Neuroendoscopes
• 10.3. Market Analysis - By Application
  • 10.3.1. Transnasal Neuroendoscopy
  • 10.3.2. Intraventricular Neuroendoscopy
  • 10.3.3. Transcranial Neuroendoscopy
• 10.4. Market Analysis - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis - By Country/ Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Ackermann Instrumente GmbH
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. strategies,
    • 11.5.1.6. financials (based on availability)
  • 11.5.2. B. Braun Aesculap
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. strategies,
    • 11.5.2.6. financials (based on availability)
  • 11.5.3. Clarus Medical LLC
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. strategies,
    • 11.5.3.6. financials (based on availability)
  • 11.5.4. KARLSTORZSE & Co. KG
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. strategies,
    • 11.5.4.6. financials (based on availability)
  • 11.5.5. Schindlerendoskopie technologie GmbH
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. strategies,
    • 11.5.5.6. financials (based on availability)
  • 11.5.6. Tonglu WANHE Medical Instrument
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. strategies,
    • 11.5.6.6. financials (based on availability)
  • 11.5.7. HAWK
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. strategies,
    • 11.5.7.6. financials (based on availability)
  • 11.5.8. Machida Endoscope
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. strategies,
    • 11.5.8.6. financials (based on availability)
  • 11.5.9. Adeor medical AG
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. strategies,
    • 11.5.9.6. financials (based on availability)
  • 11.5.10. Nevro Corporation
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. strategies,
    • 11.5.10.6. financials (based on availability)

12. Strategic Recommendations